ClinicalTrials.gg
TerminatedNCT01106209Updated Mar 18, 2025Results posted

Neutrophil Extracellular Trap Formation in Newborn Infants at Risk for Inflammatory Syndromes

An observational study in Prematurity and Necrotizing Enterocolitis, sponsored by University of Utah. Terminated at 2 sites in United States. Open to participants aged Up to 1 Year, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-03-18.

Sponsored by University of Utah · Observational

Why this study was terminated
Lack of enrollment
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
14
Ages
Up to 1 Year
Sex
All
01

Study summary

The purpose of this study is to characterize the time to maturation of neutrophil extracellular trap(NET) formation capability in polymorphonuclear leukocytes(PMNs) isolated from newborn premature and term infants. Preterm infants who are enrolled into the study who then go on to require surgery \<1 year due to surgical NEC, will have the NET formation reassessed. This study will also determine whether NETs contribute to the pathogenesis of necrotizing enterocolitis (NEC). We hypothesize that NET formation contributes to the pathogenesis of NEC by inappropriately releasing degradative proteins and tissue destructive enzymes into the inflammatory milieu of the premature infant gastrointestinal tract following bacterial translocation. We also hypothesize that the delay in NEC development in premature infants (3rd - 4th week of life) as compared to at-risk term infants (1st week of life) results from a developmental delay in PMN ability to form NETs.

Read the detailed description

Prematurely born infants are at risk for necrotizing enterocolitis (NEC), the most common gastrointestinal emergency encountered in the newborn intensive care unit. This disease occurs in between 5 - 10% of infants born at less than 30 weeks gestation or less than 1500 grams birth weight. In these patients, NEC routinely develops during the 3rd or 4th week of life. NEC rarely occurs in infants born closer to term; for these patients NEC usually develops during the 1st week of life. So far, no one has explained the inverse relationship between gestational age at birth and the delay in NEC development.

Recently, our laboratory described for the first time an inherent deficiency of innate immunity in newborn infants - failure of neutrophil extracellular trap formation. Neutrophil extracellular traps or NETs are complex lattices of extracellular chromatin and DNA decorated with anti-microbial proteins and degradative enzymes which trap and kill microbes. When the neutrophils of newborn infants develop the ability to form NETs and whether the maturation of NET formation correlates with development of NEC in at risk infants remains unknown.

We have therefore undertaken the following study best described as a prospective, in vitro longitudinal cellular biology study of LPS/PAF-stimulated PMNs isolated from the cord and peripheral blood of premature infants at risk for NEC and from term infants not considered at risk for NEC. We will also assay for NET formation in gastrointestinal tissue samples obtained at the time of surgery for severe NEC in enrolled prematurely born infants. These studies are the first of their kind and aim to answer these important questions.

02

Conditions studied

  • Prematurity
  • Necrotizing Enterocolitis

Keywords

  • premature infants
  • polymorphonuclear leukocytes
  • PMNs
  • neutrophil extracellular traps
  • NET formation
  • necrotizing enterocolitis
03

In context

Premature Birth

2,550 studies on the registry are indexed under Premature Birth; 500 are open to participants now.

This study's enrollment of 14 is below the median of 120 across 806 observational studies indexed under Premature Birth.

Browse Premature Birth studies →

Lead sponsor

University of Utah is the lead sponsor of 994 studies on the registry; 175 are open to participants now.

Of its 114 completed or terminated interventional studies of FDA-regulated products, 69 (61%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Up to 1 Year
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Preterm and healthy term infants born at the University of Utah Hospital. A subset of preterm infants needing surgery \<1 year of age, will be reassessed.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Preterm infant patients delivered at UUMC and hospitalized in the NICU who are ≤ 1500 grams or \<30 weeks gestational age at birth
  2. Term infants delivered at UUMC without complication, either via cesarean section or vaginal delivery

Exclusion criteria

Exclusion Criteria:

  • No other exclusion criteria
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
14 participants (actual)
Biospecimen retention
Samples with dna

Groups and cohorts

  • Prematurely born infants in the NICU

    Preterm infant patients delivered at UUMC and hospitalized in the NICU who are ≤1500 grams or \<30 weeks gestational age at birth.

  • Healthy term infants

    Term infants delivered at UUMC without complication, either via cesarean section or vaginal delivery

  • Subset: Enrolled preterm infants having surgery at <1 year old for NEC

    Enrolled preterm infants who require surgery for NEC within their first year of life for

06

What researchers measure

Primary outcomes

  1. Time to Maturation of Neutrophil Extracellular Trap(NET) Formation

    The objective is to characterize the time to maturation of NET formation capability in polymorphonuclear leukocytes(PMNs)isolated from newborn infants.

    Time frame: 60 days

07

Results

Posted Mar 18, 2025
Limitations and caveats
This is an observational study designed to evaluate NEC incidence with in vitro assessment of neutrophil neutrophil extracellular trap formation. There are too few study participants to draw any meaningful correlations between in vitro NET formation by participant neutrophils and the incidence of NEC in this at-risk population.

Participant flow

Participant flow — Overall Study
MilestonePrematurely Born Infants in the NICUHealthy Term InfantsInfants Having Surgery at <1 Year Old
Started1130
Completed1130
Not completed000

Outcome measures

PrimaryTime to Maturation of Neutrophil Extracellular Trap(NET) Formation

The objective is to characterize the time to maturation of NET formation capability in polymorphonuclear leukocytes(PMNs)isolated from newborn infants.

Time frame:
60 days
Reported as:
Mean · Days
Time to Maturation of Neutrophil Extracellular Trap(NET) Formation
DaysPrematurely Born Infants in the NICUHealthy Term InfantsInfants Having Surgery at <1 Year Old
Time to Maturation of Neutrophil Extracellular Trap(NET) Formation14 (3 to 17)5 (4 to 14)—

Adverse events

Collected over First 2 months of life.. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Prematurely Born Infants in the NICU1/11 (9.1%)0/11 (0%)0/11 (0%)
Healthy Term Infants0/3 (0%)0/3 (0%)0/3 (0%)
Infants Having Surgery at <1 Year Old———

Baseline characteristics

None of our recruited prematurely born infants in the NICU required surgery in the first year of life.

Age, Categorical
Age, Categorical(Participants)Prematurely Born Infants in the NICUHealthy Term InfantsSubset: Enrolled Preterm Infants Having Surgery at <1 Year OldTotal
<=18 years113014
Between 18 and 65 years0000
>=65 years0000
Age, Continuous
Age, Continuous(Day)Prematurely Born Infants in the NICUHealthy Term InfantsSubset: Enrolled Preterm Infants Having Surgery at <1 Year OldTotal
Mean1 (1 to 1)1 (1 to 1)—1 (1 to 1)
Sex: Female, Male
Sex: Female, Male(Participants)Prematurely Born Infants in the NICUHealthy Term InfantsSubset: Enrolled Preterm Infants Having Surgery at <1 Year OldTotal
Female61—7
Male52—7
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Prematurely Born Infants in the NICUHealthy Term InfantsSubset: Enrolled Preterm Infants Having Surgery at <1 Year OldTotal
Hispanic or Latino20—2
Not Hispanic or Latino93—12
Unknown or Not Reported00—0
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Prematurely Born Infants in the NICUHealthy Term InfantsSubset: Enrolled Preterm Infants Having Surgery at <1 Year OldTotal
American Indian or Alaska Native00—0
Asian00—0
Native Hawaiian or Other Pacific Islander00—0
Black or African American00—0
White113—14
More than one race00—0
Unknown or Not Reported00—0
Region of Enrollment
Region of Enrollment(participants)Prematurely Born Infants in the NICUHealthy Term InfantsSubset: Enrolled Preterm Infants Having Surgery at <1 Year OldTotal
United States113—14
08

Study locations

2 sites
  • University of Utah
    Salt Lake City, Utah 84108, United States
  • Primary Children's Medical Center
    Salt Lake City, Utah 84112, United States
09

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 18, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT01106209
Lead sponsor
University of Utah
Responsible party
Sponsor
First posted
Apr 19, 2010
Start date
Apr 2010
Primary completion
Jun 22, 2020
Completion
Jun 22, 2020
Results posted
Mar 18, 2025
Last update
Mar 18, 2025

Study contacts

Christian C Yost, MD
principal investigator · University of Utah

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Nov 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion